Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia [11]

British Journal of Dermatology

Volumn 154, Issue 6, 2006, Pages 1216-1218

  Deguchi, N ^a   Kawamura, T ^a   Shimizu, A ^a   Kitamura, R ^a   Yanagi, M ^a   Shibagaki, N ^a   Matsue, H ^a   Shimada, S ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DIARRHEA; EDEMA; FEMALE; HIGH RISK PATIENT; HUMAN; KERATOSIS PALMOPLANTARIS; LETTER; MALE; NAIL DYSTROPHY; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT;

AGED; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; KERATODERMA, PALMOPLANTAR; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NAIL DISEASES; PIPERAZINES; PYRIMIDINES;

EID: 33646538818     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07279.x     Document Type: Letter

References (4)

1. Kantarjian H Sawyers C Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia N Engl J Med 2002 346 645 52
2. Valeyrie L Bastuji-Garin S Revuz J et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients J Am Acad Dermatol 2003 48 201 6
3. Krane JF Murphy DP Gottlieb AB et al. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis J Invest Dermatol 1991 96 983 6
4. Yamamoto T Katayama I Nishioka K. Possible contribution of stem cell factor in psoriasis vulgaris J Dermatol Sci 2000 24 171 6